Medicine :: Setting sights on the drugs of the future
Researchers at the University of Nottingham have joined forces with one of the world?s leading pharmaceutical companies, AstraZeneca, to single out potential medicines of the future.
Researchers at the University of Nottingham have joined forces with one of the world?s leading pharmaceutical companies, AstraZeneca, to single out potential medicines of the future.
Older women with breast cancer get a lower level of care than younger women, researchers at the University of Manchester have found.
Soldiers exposed to the deafening din of battle have little defense against hearing loss, and are often reluctant to wear protective gear like ear plugs that could make them less able to react to danger. But what if a nutritious daily “candy bar” could prevent much of that potential damage to their hearing?
A common asthma inhaler powered by a new propellant is safe and effective but could come at nearly triple the cost to consumers until a generic version hits the market, according to a review in today’s (March 29) New England Journal of Medicine.
If good genes spread through the population, why are people so different? A group of scientists think they have solved this long-standing puzzle.
Women with a recent diagnosis of cancer in one breast should have MRI screening of the opposite breast, concludes a multi-center study involving University of North Carolina at Chapel Hill researchers.
The Liverpool School of Tropical Medicine has received a $23 million grant from the Bill & Melinda Gates Foundation to help victims of human filariasis — a worm infection which causes some of the world?s most debilitating and distressing diseases.
People are mixing supplements, herbs and over-the-counter medications and prescription drugs to cure themselves of ills, unaware that they could be making themselves sicker, says George Grossberg, M.D., director of the division of geriatric psychiatry at Saint Louis University.
Diabetes and high blood pressure, two conditions rooted in genetics and environmental surroundings, play a much greater role than race alone in determining who is mostly likely to develop heart failure, according to the latest study from cardiologists at Johns Hopkins. Each year, nearly 300,000 Americans die from heart failure.
Researchers today reported that an investigational anti-hypertensive therapy may perform better in controlling blood pressure than standard treatments for patients undergoing heart surgery, during a presentation at the American College of Cardiology?s 56th Annual Scientific Session.